Chargement en cours...
Profile of eliglustat tartrate in the management of Gaucher disease
Gaucher disease (GD) is a lysosomal storage disorder caused by the deficient activity of acid beta glucosidase, with consequent accumulation of glucosylceramide in the spleen, liver, bone marrow, and various organs and tissues. Currently, the gold standard for GD treatment is enzyme replacement ther...
Enregistré dans:
| Publié dans: | Ther Clin Risk Manag |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4714736/ https://ncbi.nlm.nih.gov/pubmed/26811686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S73226 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|